{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:05:15Z","timestamp":1792029915583,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["miND BSC 0115"],"award-info":[{"award-number":["miND BSC 0115"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Higher Education Dept., Govt. of Kerala"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12035-016-0328-y","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T04:48:54Z","timestamp":1483678134000},"page":"804-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Debashis","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emili","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Naskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh Kumar","family":"Paidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kochupurackal P","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"key":"328_CR1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302:819\u2013822","journal-title":"Science"},{"key":"328_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386","journal-title":"Neurology"},{"key":"328_CR3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","volume":"75","author":"GF Wooten","year":"2004","unstructured":"Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are men at greater risk for Parkinson\u2019s disease than women? J Neurol Neurosurg Psychiatry 75:637\u2013639","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"328_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/jnnp.2006.104695","volume":"78","author":"KS Taylor","year":"2007","unstructured":"Taylor KS, Cook JA, Counsell CE (2007) Heterogeneity in male to female risk for Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78:905\u2013906","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"328_CR5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med 318:876\u2013880","journal-title":"N Engl J Med"},{"key":"328_CR6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122:1437\u20131448","journal-title":"Brain"},{"key":"328_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2010.04.061","volume":"1343","author":"S Phani","year":"2010","unstructured":"Phani S, Gonye G, Iacovitti L (2010) VTA neurons show a potentially protective transcriptional response to MPTP. Brain Res 1343:1\u201313","journal-title":"Brain Res"},{"key":"328_CR8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1742-4658.2008.06302.x","volume":"275","author":"M Terzioglu","year":"2008","unstructured":"Terzioglu M, Galter D (2008) Parkinson\u2019s disease: genetic versus toxin-induced rodent models. FEBS J 275:1384\u20131391","journal-title":"FEBS J"},{"key":"328_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","volume":"2","author":"MF Beal","year":"2001","unstructured":"Beal MF (2001) Experimental models of Parkinson\u2019s disease. Nat Rev Neurosci 2:325\u2013334","journal-title":"Nat Rev Neurosci"},{"key":"328_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-211-45295-0_39","volume":"70","author":"EC Hirsch","year":"2006","unstructured":"Hirsch EC (2006) How to judge animal models of Parkinson\u2019s disease in terms of neuroprotection. J Neural Transm Suppl 70:255\u2013260","journal-title":"J Neural Transm Suppl"},{"key":"328_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00702-010-0434-3","volume":"118","author":"Z Lv","year":"2011","unstructured":"Lv Z, Jiang H, Xu H, Song N, Xie J (2011) Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson\u2019s disease. J Neural Transm 118:361\u2013369","journal-title":"J Neural Transm"},{"key":"328_CR12","doi-asserted-by":"crossref","first-page":"8314","DOI":"10.1523\/JNEUROSCI.1972-07.2007","volume":"27","author":"CY Chung","year":"2007","unstructured":"Chung CY, Koprich JB, Endo S, Isacson O (2007) An endogenous serine\/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson\u2019s disease. J Neurosci 27:8314\u20138323","journal-title":"J Neurosci"},{"key":"328_CR13","doi-asserted-by":"crossref","first-page":"22474","DOI":"10.1073\/pnas.0912193106","volume":"52","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Hallett PJ, Isacson O (2009) Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Proc Natl Acad Sci U S A 52:22474\u201322479","journal-title":"Proc Natl Acad Sci U S A"},{"key":"328_CR14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nn.2661","volume":"13","author":"M Di Salvio","year":"2010","unstructured":"Di Salvio M, Di Giovannantonio LG, Acampora D, Prosperi R, Omodei D, Prakash N, Wurst W, Simeone A (2010) Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP. Nat Neurosci 13:1481\u20131488","journal-title":"Nat Neurosci"},{"key":"328_CR15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"304","author":"JT Greenamyre","year":"2004","unstructured":"Greenamyre JT, Hastings TG (2004) Biomedicine. Parkinson\u2019s\u2014divergent causes, convergent mechanisms. Science 304:1120\u20131122","journal-title":"Science"},{"key":"328_CR16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","volume":"62","author":"EV Mosharov","year":"2009","unstructured":"Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K et al (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218\u2013229","journal-title":"Neuron"},{"key":"328_CR17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nn941","volume":"5","author":"TM Dawson","year":"2002","unstructured":"Dawson TM, Dawson VL (2002) Neuroprotective and neurorestorative strategies for Parkinson\u2019s disease. Nat Neurosci 5:1058\u20131061","journal-title":"Nat Neurosci"},{"key":"328_CR18","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/ana.10481","volume":"53","author":"S Hunot","year":"2003","unstructured":"Hunot S, Hirsch EC (2003) Neuroinflammatory processes in Parkinson\u2019s disease. Ann Neurol 53:S49\u2013S58","journal-title":"Ann Neurol"},{"key":"328_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2009.03.006","volume":"218","author":"H Bueler","year":"2009","unstructured":"Bueler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson\u2019s disease. Exp Neurol 218:235\u2013246","journal-title":"Exp Neurol"},{"key":"328_CR20","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1073\/pnas.0405340101","volume":"101","author":"J Grimm","year":"2004","unstructured":"Grimm J, Mueller A, Hefti F, Rosenthal A (2004) Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U S A 101:13891\u201313896","journal-title":"Proc Natl Acad Sci U S A"},{"key":"328_CR21","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M116.714824","volume":"291","author":"G Chandra","year":"2016","unstructured":"Chandra G, Rangasamy SB, Roy A, Kordower JH, Pahan K (2016) Neutralization of RANTES and eotaxin prevents the loss of dopaminergic neurons in a mouse model of Parkinson disease. J Biol Chem 291:15267\u201315281","journal-title":"J Biol Chem"},{"key":"328_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.13409","volume":"136","author":"AB Mu\u00f1oz-Manchado","year":"2016","unstructured":"Mu\u00f1oz-Manchado AB, Villadiego J, Romo-Madero S, Su\u00e1rez-Luna N, Bermejo-Navas A, Rodr\u00edguez-G\u00f3mez JA, Garrido-Gil P, Labandeira-Garc\u00eda JL et al (2016) Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice. J Neurochem 136:373\u2013387","journal-title":"J Neurochem"},{"key":"328_CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jpi.12212","volume":"58","author":"A Naskar","year":"2015","unstructured":"Naskar A, Prabhakar V, Singh R, Dutta D, Mohanakumar KP (2015) Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. J Pineal Res 58:262\u2013274","journal-title":"J Pineal Res"},{"key":"328_CR24","doi-asserted-by":"crossref","unstructured":"Chandramouli K, Qian PY (2009) Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. Hum Genomics Proteomics pii: 239204","DOI":"10.4061\/2009\/239204"},{"key":"328_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1113\/jphysiol.2006.112599","volume":"575","author":"JG Greene","year":"2006","unstructured":"Greene JG (2006) Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J Physiol 575:411\u2013416","journal-title":"J Physiol"},{"key":"328_CR26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0891-5849(97)00206-2","volume":"24","author":"HC Hung","year":"1998","unstructured":"Hung HC, Lee EH (1998) MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic Biol Med 24:76\u201384","journal-title":"Free Radic Biol Med"},{"key":"328_CR27","doi-asserted-by":"crossref","first-page":"e21720","DOI":"10.1371\/journal.pone.0021720","volume":"6","author":"SR Slone","year":"2011","unstructured":"Slone SR, Lesort M, Yacoubian TA (2011) 14-3-3Theta protects against neurotoxicity in a cellular Parkinson\u2019s disease model through inhibition of the apoptotic factor Bax. PLoS One 6:e21720","journal-title":"PLoS One"},{"key":"328_CR28","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1074\/jbc.M901310200","volume":"284","author":"J Wang","year":"2009","unstructured":"Wang J, Lou H, Pedersen CJ, Smith AD, Perez RG (2009) 14-3-3Zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria. J Biol Chem 284:14011\u201314019","journal-title":"J Biol Chem"},{"key":"328_CR29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","volume":"67","author":"L Alvarez-Erviti","year":"2010","unstructured":"Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67:1464\u20131472","journal-title":"Arch Neurol"},{"key":"328_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4161\/cib.18483","volume":"5","author":"S Pemberton","year":"2012","unstructured":"Pemberton S, Melki R (2012) The interaction of Hsc70 protein with fibrillar alpha-synuclein and its therapeutic potential in Parkinson\u2019s disease. Commun Integr Biol 5:94\u201395","journal-title":"Commun Integr Biol"},{"key":"328_CR31","doi-asserted-by":"crossref","first-page":"34690","DOI":"10.1074\/jbc.M111.261321","volume":"286","author":"S Pemberton","year":"2011","unstructured":"Pemberton S, Madiona K, Pieri L, Kabani M, Bousset L, Melki R (2011) Hsc70 protein interaction with soluble and fibrillar alpha-synuclein. J Biol Chem 286:34690\u201334699","journal-title":"J Biol Chem"},{"key":"328_CR32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"PK Auluck","year":"2002","unstructured":"Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a drosophila model for Parkinson\u2019s disease. Science 295:865\u2013868","journal-title":"Science"},{"key":"328_CR33","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1074\/jbc.M412106200","volume":"280","author":"PK Auluck","year":"2005","unstructured":"Auluck PK, Meulener MC, Bonini NM (2005) Mechanisms of suppression of {alpha}-synuclein neurotoxicity by geldanamycin in drosophila. J Biol Chem 280:2873\u20132878","journal-title":"J Biol Chem"},{"key":"328_CR34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1523\/JNEUROSCI.2849-11.2012","volume":"32","author":"P Zhou","year":"2012","unstructured":"Zhou P, Qian L, D\u2019Aurelio M, Cho S, Wang G, Manfredi G, Pickel V, Iadecola C (2012) Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J Neurosci 32:583\u2013592","journal-title":"J Neurosci"},{"key":"328_CR35","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1021\/bi2008933","volume":"50","author":"SR Sripathi","year":"2011","unstructured":"Sripathi SR, He W, Atkinson CL, Smith JJ, Liu Z, Elledge BM, Jahng WJ (2011) Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress. Biochemistry 50:8342\u20138351","journal-title":"Biochemistry"},{"key":"328_CR36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1091\/mbc.E04-09-0807","volume":"16","author":"T Tatsuta","year":"2005","unstructured":"Tatsuta T, Model K, Langer T (2005) Formation of membrane-bound ring complexes by prohibitins in mitochondria. Mol Biol Cell 16:248\u2013259","journal-title":"Mol Biol Cell"},{"key":"328_CR37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2008.09.014","volume":"1792","author":"MK Borland","year":"2009","unstructured":"Borland MK, Mohanakumar KP, Rubinstein JD, Keeney PM, Xie J, Capaldi R, Dunham LD, Trimmer PA et al (2009) Relationships among molecular genetic and respiratory properties of Parkinson\u2019s disease cybrid cells show similarities to Parkinson\u2019s brain tissues. Biochim Biophys Acta 1792:68\u201374","journal-title":"Biochim Biophys Acta"},{"key":"328_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2008.12.021","volume":"279","author":"M Varghese","year":"2009","unstructured":"Varghese M, Pandey M, Samanta A, Gangopadhyay PK, Mohanakumar KP (2009) Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson\u2019s disease, but not Parkinson plus patients, from an Indian population. J Neurol Sci 279:39\u201342","journal-title":"J Neurol Sci"},{"key":"328_CR39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuint.2010.04.005","volume":"57","author":"B Park","year":"2010","unstructured":"Park B, Yang J, Yun N, Choe KM, Jin BK, Oh YJ (2010) Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model. Neurochem Int 57:16\u201332","journal-title":"Neurochem Int"},{"key":"328_CR40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli C, Gigu\u00e8re N, Bourque MJ, L\u00e9vesque M, Slack RS, Trudeau L\u00c9 (2015) Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr Biol 25:2349\u20132360","journal-title":"Curr Biol"},{"key":"328_CR41","doi-asserted-by":"crossref","unstructured":"Greene JG, Dingledine R, Greenamyre JT (2010) Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents. Neurobiol Dis 38:476\u2013481","DOI":"10.1016\/j.nbd.2010.03.014"},{"key":"328_CR42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2007.01.026","volume":"415","author":"I Ferrer","year":"2007","unstructured":"Ferrer I, Perez E, Dalfo E, Barrachina M (2007) Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson\u2019s disease. Neurosci Lett 415:205\u2013209","journal-title":"Neurosci Lett"},{"key":"328_CR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj20021525","volume":"371","author":"SV Kalivendi","year":"2003","unstructured":"Kalivendi SV, Kotamraju S, Cunningham S, Shang T, Hillard CJ, Kalyanaraman B (2003) 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem J 371:151\u2013164","journal-title":"Biochem J"},{"key":"328_CR44","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/emboj\/19.11.2444","volume":"19","author":"LG Nijtmans","year":"2000","unstructured":"Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, Back JW, Muijsers AO, van der Spek H et al (2000) Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J 19:2444\u20132451","journal-title":"EMBO J"},{"key":"328_CR45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/BJ20101685","volume":"436","author":"RB Parsons","year":"2011","unstructured":"Parsons RB, Aravindan S, Kadampeswaran A, Evans EA, Sandhu KK, Levy ER, Thomas MG, Austen BM et al (2011) The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of complex I inhibitors. Biochem J 436:145\u2013155","journal-title":"Biochem J"},{"key":"328_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroscience.2014.11.037","volume":"286","author":"L Li","year":"2015","unstructured":"Li L, Guo JD, Wang HD, Shi YM, Yuan YL, Hou SX (2015) Prohibitin 1 gene delivery promotes functional recovery in rats with spinal cord injury. Neuroscience 286:27\u201336","journal-title":"Neuroscience"},{"key":"328_CR47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.lfs.2011.06.022","volume":"89","author":"I Chowdhury","year":"2011","unstructured":"Chowdhury I, Branch A, Olatinwo M, Thomas K, Matthews R, Thompson WE (2011) Prohibitin (PHB) acts as a potent survival factor against ceramide induced apoptosis in rat granulosa cells. Life Sci 89:295\u2013303","journal-title":"Life Sci"},{"key":"328_CR48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2220\/biomedres.31.113","volume":"31","author":"T Muraguchi","year":"2010","unstructured":"Muraguchi T, Kawawa A, Kubota S (2010) Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death. Biomed Res 31:113\u2013122","journal-title":"Biomed Res"},{"key":"328_CR49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","volume":"12","author":"D Muralikrishnan","year":"1998","unstructured":"Muralikrishnan D, Mohanakumar KP (1998) Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. FASEB J 12:905\u2013912","journal-title":"FASEB J"},{"key":"328_CR50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3174\/ajnr.A1401","volume":"30","author":"ES Manova","year":"2009","unstructured":"Manova ES, Habib CA, Boikov AS, Ayaz M, Khan A, Kirsch WM, Kido DK, Haacke EM (2009) Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol 30:569\u2013574","journal-title":"AJNR Am J Neuroradiol"},{"key":"328_CR51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/jnr.23241","volume":"91","author":"TA Appukuttan","year":"2013","unstructured":"Appukuttan TA, Ali N, Varghese M, Singh A, Tripathy D, Padmakumar M, Gangopadhyay PK, Mohanakumar KP (2013) Parkinson\u2019s disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids. J Neurosci Res 91:963\u2013970","journal-title":"J Neurosci Res"},{"key":"328_CR52","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. Academic, San Diego"},{"key":"328_CR53","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/pr100389u","volume":"9","author":"G Lessner","year":"2010","unstructured":"Lessner G, Schmitt O, Haas SJ, Mikkat S, Kreutzer M, Wree A, Glocker MO (2010) Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes. J Proteome Res 9:4671\u20134687","journal-title":"J Proteome Res"},{"key":"328_CR54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"328_CR55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1559-0275-9-11","volume":"9","author":"NM Boukli","year":"2012","unstructured":"Boukli NM, Shetty V, Cubano L, Ricaurte M, Coelho-Dos-Reis J, Nickens Z, Shah P, Talal AH et al (2012) Unique and differential protein signatures within the mononuclear cells of HIV-1 and HCV mono-infected and co-infected patients. Clin Proteomics 9:11","journal-title":"Clin Proteomics"},{"key":"328_CR56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/BJ20040256","volume":"383","author":"I Bourges","year":"2004","unstructured":"Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, Cardol P, Hofhaus G, Issartel JP (2004) Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin. Biochem J 383:491\u2013499","journal-title":"Biochem J"},{"key":"328_CR57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"328_CR58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cns.12189","volume":"20","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP (2014) Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. CNS Neurosci Ther 20:10\u201319","journal-title":"CNS Neurosci Ther"},{"key":"328_CR59","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, Schneider BL, Lee MK (2012) Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci 32:3306\u20133320","journal-title":"J Neurosci"},{"key":"328_CR60","doi-asserted-by":"crossref","first-page":"e31231","DOI":"10.1371\/journal.pone.0031231","volume":"7","author":"AS Kathiria","year":"2012","unstructured":"Kathiria AS, Butcher LD, Feagins LA, Souza RF, Boland CR, Theiss AL (2012) Prohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLoS One 7:e31231","journal-title":"PLoS One"},{"key":"328_CR61","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","volume":"2","author":"J Luo","year":"2007","unstructured":"Luo J, Deng Z, Luo X, Tang N, Song W, Chen J, Sharff KA, Luu HH et al (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2:1236\u20131247","journal-title":"Nat Protoc"},{"key":"328_CR62","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","volume":"70","author":"N Mittereder","year":"1996","unstructured":"Mittereder N, March KL, Trapnell BC (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70:7498\u20137509","journal-title":"J Virol"},{"key":"328_CR63","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1038\/cddis.2013.148","volume":"4","author":"P Sanphui","year":"2013","unstructured":"Sanphui P, Biswas SC (2013) FoxO3a is activated and executes neuron death via Bim in response to beta-amyloid. Cell Death Dis 4:e625","journal-title":"Cell Death Dis"},{"key":"328_CR64","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1113\/jphysiol.2012.228387","volume":"590","author":"AA Gerencser","year":"2012","unstructured":"Gerencser AA, Chinopoulos C, Birket MJ, Jastroch M, Vitelli C, Nicholls DG, Brand MD (2012) Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium-induced de- and hyperpolarization of neuronal mitochondria. J Physiol 590:2845\u20132871","journal-title":"J Physiol"},{"key":"328_CR65","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1523\/JNEUROSCI.2614-08.2008","volume":"28","author":"J Verburg","year":"2008","unstructured":"Verburg J, Hollenbeck PJ (2008) Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling. J Neurosci 28:8306\u20138315","journal-title":"J Neurosci"},{"key":"328_CR66","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1471-4159.1999.0730322.x","volume":"73","author":"BS Jeon","year":"1999","unstructured":"Jeon BS, Kholodilov NG, Oo TF, Kim SY, Tomaselli KJ, Srinivasan A, Stefanis L, Burke RE (1999) Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 73:322\u2013333","journal-title":"J Neurochem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0328-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T17:32:33Z","timestamp":1658338353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0328-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0328-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]}}}